Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 3Thoracic 1Other 1

Conditions

Lung Neoplasms 1332Carcinoma, Non-Small-Cell Lung 631Breast Neoplasms 162Neoplasms 99Small Cell Lung Carcinoma 93Prostatic Neoplasms 86Colorectal Neoplasms 79Motor Activity 63Colonic Neoplasms 62Head and Neck Neoplasms 60Esophageal Neoplasms 49Disease 46Pancreatic Neoplasms 45Melanoma 41Stomach Neoplasms 39Urinary Bladder Neoplasms 37Ovarian Neoplasms 37Pleural Effusion, Malignant 36Neoplasm Metastasis 35Brain Neoplasms 29Gastrointestinal Neoplasms 28Pulmonary Disease, Chronic Obstructive 27Anxiety Disorders 27Lung Diseases 26Liver Neoplasms 26Carcinoma, Renal Cell 26Adenocarcinoma of Lung 26Thoracic Neoplasms 25Mesothelioma 24Lymphoma 24

Interventions

Losartan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Radiation Fibrosis Syndrome × Thoracic × Clear all
NCT00880386 2017-05-02

Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer

University of South Florida

Phase NA Withdrawn
OtherThoracic

Radiation Fibrosis Syndrome, Carcinoma, Non-Small-Cell Lung, Dyspnea, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡